{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:12:38Z","timestamp":1779351158120,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Loperamide is a widely available oral \u03bc-opioid receptor agonist, and loperamide abuse is increasing by those seeking intoxication. Loperamide has potent QTc-prolonging properties, placing patients at risk for ventricular arrhythmias and sudden cardiac death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>A 23-year-old woman was found to be in pulseless ventricular fibrillation with a QTc of 554\u2009ms and received multiple defibrillations and IV lidocaine. Her toxicology studies were negative. She subsequently experienced multiple episodes of torsades de pointes and was found to be in cardiogenic shock with a left ventricular ejection fraction of 5%. Following multiple defibrillations, an Impella\u00ae mechanical circulatory support device was placed, and she was given IV magnesium and IV lidocaine. After mechanical circulatory support was withdrawn, she experienced major bleeding and was found to have a deep vein thrombosis, bilateral radial artery thrombosis, and multiple pulmonary embolisms in the setting of heparin-induced thrombocytopenia. After stabilizing, she admitted to taking 80 tablets of loperamide 2\u2009mg in pursuit of euphoria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Loperamide is an increasingly popular agent of abuse. Loperamide-associated ventricular arrhythmias are rare with normal doses but more common with high doses, chronic ingestion, or interacting medications. Loperamide cardiotoxicity may be prolonged due to a long half-life and accumulation. Loperamide abuse may be under-recognized, leading to delays in treatment. Intravenous fluids, magnesium supplementation, chronotropes, transcutaneous or transvenous pacing, and defibrillation may be helpful in mitigating loperamide-associated polymorphic ventricular tachycardia. Clinicians should monitor for drug interactions in patients taking loperamide and screen for electrocardiographic abnormalities in those taking chronic or high-dose loperamide.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjcr\/ytz150","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T05:32:23Z","timestamp":1569648743000},"page":"1-6","source":"Crossref","is-referenced-by-count":10,"title":["Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-2960","authenticated-orcid":false,"given":"Jonathan D","family":"Cicci","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, CB 7600, Chapel Hill, NC 27514, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-579X","authenticated-orcid":false,"given":"Sarah M","family":"Jagielski","sequence":"first","affiliation":[{"name":"UK Healthcare, 1000 S. Limestone, Room H110, Lexington, KY 40536, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan M","family":"Clarke","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, CB 7600, Chapel Hill, NC 27514, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-416X","authenticated-orcid":false,"given":"Robert A","family":"Rayson","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of North Carolina, Burnett-Womack Building, 160 Dental Circle, CB# 7075, Chapel Hill, NC 27599, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A","family":"Cavender","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of North Carolina, Burnett-Womack Building, 160 Dental Circle, CB# 7075, Chapel Hill, NC 27599, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"2020021801493041600_ytz150-B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jemermed.2017.03.018","article-title":"Intentional misuse and abuse of loperamide: a new look at a drug with \u201clow abuse potential\u201d","volume":"53","author":"Borron","year":"2017","journal-title":"J Emerg Med"},{"key":"2020021801493041600_ytz150-B2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1211\/jpp.62.04.0001","article-title":"Loperamide and P-glycoprotein inhibition: assessment of the clinical relevance","volume":"62","author":"Vandenbossche","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"2020021801493041600_ytz150-B3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00210-016-1286-7","article-title":"Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic","volume":"389","author":"Kang","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2020021801493041600_ytz150-B4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.japh.2016.12.079","article-title":"Loperamide misuse and abuse","volume":"57","author":"Miller","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2020021801493041600_ytz150-B5","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.japh.2016.11.011","article-title":"Adverse event detection using the FDA post-marketing drug safety surveillance system: cardiotoxicity associated with loperamide abuse and misuse","volume":"57","author":"Swank","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2020021801493041600_ytz150-B6","first-page":"S11","article-title":"Loperamide: a pharmacological review","volume":"7(Suppl 3)","author":"Baker","year":"2007","journal-title":"Rev Gastroenterol Disord"},{"key":"2020021801493041600_ytz150-B7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PAF.0000000000000201","article-title":"Poor man\u2019s methadone: a case report of loperamide toxicity","volume":"36","author":"Dierksen","year":"2015","journal-title":"Am J Forensic Med Pathol"},{"key":"2020021801493041600_ytz150-B8"},{"key":"2020021801493041600_ytz150-B9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/phar.1885","article-title":"Loperamide trends in abuse and misuse over 13 years: 2002-2015","volume":"37","author":"Lasoff","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2020021801493041600_ytz150-B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2012.11.003","article-title":"\u201cI just wanted to tell you that loperamide WILL WORK\u201d: a web-based study of extra-medical use of loperamide","volume":"130","author":"Daniulaityte","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2020021801493041600_ytz150-B11","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm060076r","article-title":"Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques","volume":"49","author":"Ekins","year":"2006","journal-title":"J Med Chem"},{"key":"2020021801493041600_ytz150-B12","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1113\/JP270526","article-title":"Predicting drug-induced QT prolongation and torsades de pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J Physiol"},{"key":"2020021801493041600_ytz150-B13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.amjmed.2015.05.019","article-title":"The long QT teaser: loperamide abuse","volume":"128","author":"Enakpene","year":"2015","journal-title":"Am J Med"},{"key":"2020021801493041600_ytz150-B14","year":"2016"},{"key":"2020021801493041600_ytz150-B15","year":"2017"},{"key":"2020021801493041600_ytz150-B16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15563659709001159","article-title":"Surveillance of loperamide ingestions: an analysis of 216 poison center reports","volume":"35","author":"Litovitz","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"2020021801493041600_ytz150-B17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/15563650.2015.1026971","article-title":"Loperamide toxicokinetics: serum concentrations in the overdose setting","volume":"53","author":"Eggleston","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"issue":"pii","key":"2020021801493041600_ytz150-B18","doi-asserted-by":"crossref","first-page":"bcr2013200146","DOI":"10.1136\/bcr-2013-200146","article-title":"Overdrive pacing in a patient with incessant torsades de pointes","volume":"2013","author":"Overbey","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2020021801493041600_ytz150-B19","year":"2018"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/3\/4\/1\/32501175\/ytz150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/3\/4\/1\/32501175\/ytz150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T05:26:35Z","timestamp":1721798795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/3\/4\/1\/5575238"}},"subtitle":[],"editor":[{"given":"Borislav","family":"Dinov","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Francesca","family":"Musella","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"John","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Amir","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Peregrine","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,9,27]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytz150","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,9,27]]}}}